Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 115

1.

The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.

Vogelsang M, Martinez CN, Rendleman J, Bapodra A, Malecek K, Romanchuk A, Kazlow E, Shapiro RL, Berman RS, Krogsgaard M, Osman I, Kirchhoff T.

Clin Cancer Res. 2016 Jan 5. [Epub ahead of print]

PMID:
26733611
2.

Identification of a Novel Pathogenic Germline KDR Variant in Melanoma.

Silva IP, Salhi A, Giles KM, Vogelsang M, Han SW, Ismaili N, Lui KP, Robinson EM, Wilson MA, Shapiro RL, Pavlick A, Zhong J, Kirchhoff T, Osman I.

Clin Cancer Res. 2015 Dec 2. [Epub ahead of print]

PMID:
26631613
3.

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis.

Weiss S, Darvishian F, Tadepalli J, Shapiro R, Golfinos J, Pavlick A, Polsky D, Kirchhoff T, Osman I.

BMC Cancer. 2015 Nov 23;15:926. doi: 10.1186/s12885-015-1927-0.

4.

Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.

Clendenen TV, Ge W, Koenig KL, Axelsson T, Liu M, Afanasyeva Y, Andersson A, Arslan AA, Chen Y, Hallmans G, Lenner P, Kirchhoff T, Lundin E, Shore RE, Sund M, Zeleniuch-Jacquotte A.

PLoS One. 2015 Oct 21;10(10):e0140478. doi: 10.1371/journal.pone.0140478. eCollection 2015.

5.

Inquiry into congruencies and trade-offs among conservation objectives requires a consistent typology of homogeneous types.

Kirchhoff T.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):E5905. doi: 10.1073/pnas.1517860112. Epub 2015 Oct 19. No abstract available.

6.

Germline determinants of clinical outcome of cutaneous melanoma.

Vogelsang M, Wilson M, Kirchhoff T.

Pigment Cell Melanoma Res. 2016 Jan;29(1):15-26. doi: 10.1111/pcmr.12418. Epub 2015 Nov 3. Review.

PMID:
26342156
7.

Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology.

Clendenen TV, Rendleman J, Ge W, Koenig KL, Wirgin I, Currie D, Shore RE, Kirchhoff T, Zeleniuch-Jacquotte A.

PLoS One. 2015 Aug 14;10(8):e0135943. doi: 10.1371/journal.pone.0135943. eCollection 2015.

8.

Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma.

Rendleman J, Vogelsang M, Bapodra A, Adaniel C, Silva I, Moogk D, Martinez CN, Fleming N, Shields J, Shapiro R, Berman R, Pavlick A, Polsky D, Shao Y, Osman I, Krogsgaard M, Kirchhoff T.

J Med Genet. 2015 Apr;52(4):231-9. doi: 10.1136/jmedgenet-2014-102832. Epub 2015 Jan 20.

PMID:
25604082
9.

Skin cancer risk in BRCA1/2 mutation carriers.

Gumaste PV, Penn LA, Cymerman RM, Kirchhoff T, Polsky D, McLellan B.

Br J Dermatol. 2015 Jun;172(6):1498-506. doi: 10.1111/bjd.13626. Epub 2015 Apr 29. Review.

PMID:
25524463
10.

Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma.

Rendleman J, Antipin Y, Reva B, Adaniel C, Przybylo JA, Dutra-Clarke A, Hansen N, Heguy A, Huberman K, Borsu L, Paltiel O, Ben-Yehuda D, Brown JR, Freedman AS, Sander C, Zelenetz A, Klein RJ, Shao Y, Lacher M, Vijai J, Offit K, Kirchhoff T.

PLoS One. 2014 Jul 10;9(7):e101685. doi: 10.1371/journal.pone.0101685. eCollection 2014.

11.

PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition.

Gold HL, Wengrod J, de Miera EV, Wang D, Fleming N, Sikkema L, Kirchhoff T, Hochman T, Goldberg JD, Osman I, Gardner LB.

Mol Cancer Res. 2014 Mar;12(3):433-9. doi: 10.1158/1541-7786.MCR-13-0422. Epub 2013 Dec 12.

12.

Melanoma risk loci as determinants of melanoma recurrence and survival.

Rendleman J, Shang S, Dominianni C, Shields JF, Scanlon P, Adaniel C, Desrichard A, Ma M, Shapiro R, Berman R, Pavlick A, Polsky D, Shao Y, Osman I, Kirchhoff T.

J Transl Med. 2013 Nov 4;11:279. doi: 10.1186/1479-5876-11-279.

13.

Introduction to epidemiology of breast and ovarian cancers.

Adaniel C, Kirchhoff T.

Ann Oncol. 2013 Nov;24 Suppl 8:viii61-viii62. doi: 10.1093/annonc/mdt317. No abstract available.

14.

Radiological anatomy - evaluation of integrative education in radiology.

Dettmer S, Schmiedl A, Meyer S, Giesemann A, Pabst R, Weidemann J, Wacker FK, Kirchhoff T.

Rofo. 2013 Sep;185(9):838-43. doi: 10.1055/s-0033-1335048. Epub 2013 Jul 25.

15.

Assessment of SLX4 Mutations in Hereditary Breast Cancers.

Shah S, Kim Y, Ostrovnaya I, Murali R, Schrader KA, Lach FP, Sarrel K, Rau-Murthy R, Hansen N, Zhang L, Kirchhoff T, Stadler Z, Robson M, Vijai J, Offit K, Smogorzewska A.

PLoS One. 2013 Jun 26;8(6):e66961. Print 2013.

16.

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.

Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, McGuffog L, Barrowdale D, Dunning AM, Lee A, Dennis J, Healey S, Dicks E, Soucy P, Sinilnikova OM, Pankratz VS, Wang X, Eldridge RC, Tessier DC, Vincent D, Bacot F, Hogervorst FB, Peock S, Stoppa-Lyonnet D; KConFab Investigators, Peterlongo P, Schmutzler RK, Nathanson KL, Piedmonte M, Singer CF, Thomassen M; Ontario Cancer Genetics Network, Hansen Tv, Neuhausen SL, Blanco I, Greene MH, Garber J, Weitzel JN, Andrulis IL, Goldgar DE, D'Andrea E, Caldes T, Nevanlinna H, Osorio A, van Rensburg EJ, Arason A, Rennert G, van den Ouweland AM, van der Hout AH, Kets CM, Aalfs CM, Wijnen JT, Ausems MG; HEBON; EMBRACE, Frost D, Ellis S, Fineberg E, Platte R, Evans DG, Jacobs C, Adlard J, Tischkowitz M, Porteous ME, Damiola F; GEMO Study Collaborators, Golmard L, Barjhoux L, Longy M, Belotti M, Ferrer SF, Mazoyer S, Spurdle AB, Manoukian S, Barile M, Genuardi M, Arnold N, Meindl A, Sutter C, Wappenschmidt B, Domchek SM, Pfeiler G, Friedman E, Jensen UB, Robson M, Shah S, Lazaro C, Mai PL, Benitez J, Southey MC, Schmidt MK, Fasching PA, Peto J, Humphreys MK, Wang Q, Michailidou K, Sawyer EJ, Burwinkel B, Guénel P, Bojesen SE, Milne RL, Brenner H, Lochmann M; GENICA Network, Aittomäki K, Dörk T, Margolin S, Mannermaa A, Lambrechts D, Chang-Claude J, Radice P, Giles GG, Haiman CA, Winqvist R, Devillee P, García-Closas M, Schoof N, Hooning MJ, Cox A, Pharoah PD, Jakubowska A, Orr N, González-Neira A, Pita G, Alonso MR, Hall P, Couch FJ, Simard J, Altshuler D, Easton DF, Chenevix-Trench G, Antoniou AC, Offit K.

PLoS Genet. 2013;9(3):e1003173. doi: 10.1371/journal.pgen.1003173. Epub 2013 Mar 27.

17.

Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.

Vijai J, Kirchhoff T, Schrader KA, Brown J, Dutra-Clarke AV, Manschreck C, Hansen N, Rau-Murthy R, Sarrel K, Przybylo J, Shah S, Cheguri S, Stadler Z, Zhang L, Paltiel O, Ben-Yehuda D, Viale A, Portlock C, Straus D, Lipkin SM, Lacher M, Robson M, Klein RJ, Zelenetz A, Offit K.

PLoS Genet. 2013;9(1):e1003220. doi: 10.1371/journal.pgen.1003220. Epub 2013 Jan 17.

18.

Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia.

Chavan A, Luthe L, Gebel M, Barg-Hock H, Seifert H, Raab R, Kirchhoff T, Schmuck B.

Eur Radiol. 2013 Apr;23(4):951-7. doi: 10.1007/s00330-012-2694-9. Epub 2012 Oct 31.

19.

Pivotal cultural values of nature cannot be integrated into the ecosystem services framework.

Kirchhoff T.

Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3146; author reply E3147. doi: 10.1073/pnas.1212409109. Epub 2012 Sep 24. No abstract available.

20.

Cost-effectiveness of TNF-α inhibition in active ankylosing spondylitis: a systematic appraisal of the literature.

Kirchhoff TD, Mittendorf T, Schmidt RE, Jablonka A, Merkesdal S.

Expert Rev Pharmacoecon Outcomes Res. 2012 Jun;12(3):307-17. doi: 10.1586/erp.12.19. Review.

PMID:
22812555
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk